Silence Therapeutics plc capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.00x
Net debt / equity: -0.11x
Debt / assets: 0.00x
Debt / EBITDA: -0.00x
Net debt / EBITDA: 0.07x

Liquidity & coverage

Current ratio: 9.83x
Quick ratio: 9.83x
Cash ratio: 6.70x
Interest coverage: —
EBITDA / interest: —
Working capital: $92.4M

Cash & dividend

FCF / debt: -482.88x
Cash flow / debt: -482.10x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.